Students will learn the processes of drug discovery and development from initial identification of a drug-like molecule; in vitro and in vivo pharmacodynamic and pharmacokinetic evaluation; preclinical assessment; and clinical trial design and considerations. Students will also learn about intellectual property protection for new chemical entities. Learning will utilize real-world data and primary literature to help students learn drug mechanism(s) of action in conjunction with pathophysiological processes of the major body systems. Using knowledge from previous foundational sciences courses, students will learn integrate knowledge to assess and critique data, information, and pharmacological principles. Weekly hours: 3 Lecture hoursRestriction(s): Completion of Year 1 of the Pharm.D. program. Prerequisite(s) or Corequisite(s): PHAR 290.0. Note: Students with credit for PHAR 398 Drug Discovery and Design cannot take this class for credit.
Students will learn the processes of drug discovery and development from initial identification of a drug-like molecule; in vitro and in vivo pharmacodynamic and pharmacokinetic evaluation; preclinical assessment; and clinical trial design and considerations. Students will also learn about intellectual property protection for new chemical entities. Learning will utilize real-world data and primary literature to help students learn drug mechanism(s) of action in conjunction with pathophysiological processes of the major body systems. Using knowledge from previous foundational sciences courses, students will learn integrate knowledge to assess and critique data, information, and pharmacological principles. Weekly hours: 3 Lecture hoursRestriction(s): Completion of Year 1 of the Pharm.D. program. Prerequisite(s) or Corequisite(s): PHAR 290.0. Note: Students with credit for PHAR 398 Drug Discovery and Design cannot take this class for credit.
